On January 27-28, 2026, the TBVI symposium took place in Les Diablerets, Switzerland, attracting over 115 researchers, developers, funders, and policymakers focused on tuberculosis (TB) vaccine research.

TBVI thanks all participants for attending and contributing to the success of this symposium. We look forward to continuing our activities and initiating new initiatives together with the field.

Presentations can be viewed here.